logo

IONS

Ionis Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
5.75 / 10
Netural

Analyst coverage is overwhelmingly bullish (100% Buy among 1 analyst), supported by a 66.7% historical win rate. Fund-flow data also show a good score of 7.8/10, with positive trends in block, small, and extra-large transactions, despite some negative medium/large flows. Together, these elements convey constructive sentiment, but the limited analyst base means consensus should be interpreted with caution. Overall, the stock enjoys supportive flows and opinions, adding a layer of optimism to the neutral fundamental and technical picture.

FundamentalSentiment(5.75)Technical
Fund Flow Rating
Analyst RatingBuy

Wall Street Opinions

Buy

Strong Buy

0%

Buy

100%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-02-06
InstitutionPiper Sandler
Times predicted3
Historical Win Rate66.7%
Is money flowing into or out of IONS?
  • IONS holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.75/10 (Netural).